August 2008 Volume 22 Number 8, pp 1475 - 1650
------------------------------------------------------------------
Announcing the NEW British Journal of Cancer website with
enhanced functionality
Visit http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20f8c0El
and benefit from new features, including RSS Web Feeds, Article Links
and Top Ten downloaded articles.
------------------------------------------------------------------
Why Publish in Leukemia?
Efficient peer-review, hassle-free submission, recognition...
Papers benefit from wide readership through hosting on nature.com and
inclusion in the leading abstracting and indexing services.
Rapid publication is also assured through Advance Online Publication.
To read the full Guide to Authors for Leukemia, visit
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20BIHy0E1
----------------------
EDITORIAL
----------------------
NG2 antigen is expressed in CD34+ HPCs and plasmacytoid dendritic cell
precursors: is NG2 expression in leukemia dependent on the target cell
where leukemogenesis is triggered?
C Bueno, R Montes, L Martin, I Prat, M C Hernandez, A Orfao and P
Menendez
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B2z50EL
----------------------
KEYNOTE ADDRESS
----------------------
The role of vertebral augmentation in multiple myeloma: International
Myeloma Working Group Consensus Statement
M A Hussein, F D Vrionis, R Allison, J Berenson, S Berven, E Erdem, S
Giralt, S Jagannath, R A Kyle, S LeGrand, R Pflugmacher, N Raje, S V
Rajkumar, L Randall, D Roodman, D Siegel, R Vescio, J Zonder and B G M
Durie
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B2z60EM
----------------------
SPOTLIGHT REVIEWS
----------------------
Pathogenesis and treatment of renal failure in multiple myeloma
M A Dimopoulos, E Kastritis, L Rosinol, J Blade and H Ludwig
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B2z70EN
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B2z80EO
Evidence and expertise in the management of polycythemia vera and
essential thrombocythemia
G Finazzi and T Barbui
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21A0EK
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21B0EL
----------------------
REVIEW
----------------------
Epigenetic plasticity of chromatin in embryonic and hematopoietic
stem//progenitor cells: therapeutic potential of cell reprogramming
G Zardo, G Cimino and C Nervi
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21C0EM
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21D0EN
----------------------
ORIGINAL ARTICLES
----------------------
Leukemia induction after a single retroviral vector insertion in Evi1
or Prdm16
U Modlich, A Schambach, M H Brugman, D C Wicke, S Knoess, Z Li, T
Maetzig, C Rudolph, B Schlegelberger and C Baum
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21E0EO
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21F0EP
Genome-wide identification of aberrantly methylated promoter
associated CpG islands in acute lymphocytic leukemia
S-Q Kuang, W-G Tong, H Yang, W Lin, M K Lee, Z H Fang, Y Wei, J
Jelinek, J-P Issa and G Garcia-Manero
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21G0EQ
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21H0ER
Mutations of the TP53 gene in acute myeloid leukemia are strongly
associated with a complex aberrant karyotype
C Haferlach, F Dicker, H Herholz, S Schnittger, W Kern and T Haferlach
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21I0ES
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21J0ET
Identification of NM23-H2 as a tumour-associated antigen in chronic
myeloid leukaemia
S Tschiedel, C Gentilini, T Lange, C Wolfel, T Wolfel, V Lennerz, S
Stevanovic, H-G Rammensee, C Huber, M Cross and D Niederwieser
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21K0EU
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21L0EV
Familial essential thrombocythemia with spontaneous megakaryocyte
colony formation and acquired JAK2 mutations
J R Higgs, I Sadek, P E Neumann, V W Ing, N K Renault, J N Berman and
W L Greer
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21M0EW
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21N0EX
New mutations of MPL in primitive myelofibrosis: only the MPL W515
mutations promote a G1//S-phase transition
R Chaligne, C Tonetti, R Besancenot, L Roy, C Marty, P Mossuz, J-J
Kiladjian, G Socie, D Bordessoule, M-C Le Bousse-Kerdiles, W
Vainchenker and S Giraudier
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21O0EY
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21P0EZ
Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated
cytologic, cytogenetic and molecular study by the groupe francophone
de cytogenetique hematologique
C Gervais, A Murati, C Helias, S Struski, A Eischen, E Lippert, I
Tigaud, D Penther, C Bastard, F Mugneret, B Poppe, F Speleman, P
Talmant, J VanDen Akker, L Baranger, C Barin, I Luquet, N Nadal, F
Nguyen-Khac, O Maarek, C Herens, D Sainty, G Flandrin, D Birnbaum, M-J
Mozziconacci and M Lessard
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21Q0Ea
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21R0Eb
Intracellular ABC transporter A3 confers multidrug resistance in
leukemia cells by lysosomal drug sequestration
B Chapuy, R Koch, U Radunski, S Corsham, N Cheong, N Inagaki, N Ban, D
Wenzel, D Reinhardt, A Zapf, S Schweyer, F Kosari, W Klapper, L
Truemper and G G Wulf
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21S0Ec
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21T0Ed
Aberrant expression of Notch1 interferes with the B-lymphoid phenotype
of neoplastic B cells in classical Hodgkin lymphoma
F Jundt, O Acikgoz, S-H Kwon, R Schwarzer, I Anagnostopoulos, B
Wiesner, S Mathas, M Hummel, H Stein, H M Reichardt and B Dorken
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21U0Ee
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21V0Ef
Aberrant expression of IL-22 receptor 1 and autocrine IL-22
stimulation contribute to tumorigenicity in ALK+ anaplastic large cell
lymphoma
J Dien Bard, P Gelebart, M Anand, H M Amin and R Lai
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21W0Eg
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21X0Eh
Signalling profile and antitumour activity of the novel Hsp90
inhibitor NVP-AUY922 in multiple myeloma
T Stuhmer, A Zollinger, D Siegmund, M Chatterjee, E Grella, S Knop, M
Kortum, C Unzicker, M R Jensen, C Quadt, P Chene, J Schoepfer, C
Garcia-Echeverria, H Einsele, H Wajant and R C Bargou
Abstract:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21Y0Ei
Article:
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21Z0Ej
----------------------
LETTERS TO THE EDITOR
----------------------
A pilot vaccination trial of synthetic analog peptides derived from
the BCR-ABL breakpoints in CML patients with minimal disease
P G Maslak, T Dao, M Gomez, S Chanel, J Packin, T Korontsvit, V
Zakhaleva, J Pinilla-Ibarz, E Berman and D A Scheinberg
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21a0Eq
Long-term molecular complete remission with IFN-[alpha] in Ph+ adult
acute lymphoid leukemia patients
P P Piccaluga, G Martinelli, A Isidori, M Malagola, M Rondoni, S
Paolini, M Amabile, I Iacobucci, M Baccarani and G Visani
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21b0Er
Successful peripheral blood stem cell mobilization with granulocyte
colony-stimulating factor in a patient with chronic myeloid leukemia
achieving a complete cytogenetic remission with dasatinib after
failing imatinib
I Gabriel, A Chaidos, J Sorouri, E Dannie, J Davis, J Goldman, J
Apperley and D Marin
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21c0Es
BRAF mutations are very rare in B- and T-cell pediatric acute
lymphoblastic leukemias
J Davidsson, H Lilljebjorn, I Panagopoulos, T Fioretos and B Johansson
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21d0Et
Splenic marginal zone lymphomas and lymphoplasmacytic lymphomas
originate from B-cell compartments with two different antigen-exposure
histories
M Parrens, N Gachard, B Petit, A Marfak, E Troadec, K Bouabdhalla, N
Milpied, J P Merlio, A de Mascarel, C Laurent, I Soubeyran, V Coste, F
Labrousse, M Cogne and J Feuillard
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21e0Eu
Gefitinib potentiates myeloid cell differentiation by ATRA
M B Miranda, R Duan, S M Thomas, J R Grandis, R L Redner, J E Jones
and D E Johnson
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21f0Ev
The feasibility of using topotecan, vinorelbine, thiotepa and
gemcitabine (TVTG) in adult patients with relapsed//refractory acute
lymphoblastic leukaemia//lymphoma
P Hiwarkar, H-T Arkenau, J Treleaven, G Morgan, M Potter and M Ethell
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21g0Ew
Lack of association of the heparanase gene single-nucleotide
polymorphism Arg307Lys with acute lymphoblastic leukaemia in patients
from Northern Ireland
P C Winter, M F McMullin and M A Catherwood
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21h0Ex
Reply to /`Lack of association of the heparanase gene
single-nucleotide polymorphism Arg307Lys with acute lymphoblastic
leukemia in patients from Northern Ireland/' by Winter et al.
O Ostrovsky, M Korostishevsky and A Nagler
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21i0Ey
Reply to Ostrovosky et al.
P C Winter, M F McMullin and M A Catherwood
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21j0Ez
Reply to Winter et al.
O Ostrovsky, M Korostishevsky and A Nagler
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21k0E1
Making progress in treating multiple myeloma with total therapies:
issue of complete remission and more
B Barlogie, F van Rhee, J D Shaughnessy, E Anaissie and J Crowley
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21l0E2
Bortezomib therapy in myelofibrosis: a phase II clinical trial
R A Mesa, S Verstovsek, C Rivera, A Pardanani, K Hussein, T Lasho, W
Wu and A Tefferi
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21m0E3
What do we mean by sensitivity when we talk about detecting minimal
residual disease?
D Steinbach and K-M Debatin
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21n0E4
ETV6 mutations and loss in AML-M0
F P G Silva, B Morolli, C T Storlazzi, A Zagaria, L Impera, B Klein, H
Vrieling, H C Kluin-Nelemans and M Giphart-Gassler
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21o0E5
Low frequency of the glutathione-S-transferase T1-null genotype in
patients with primary myelodysplastic syndrome and 5q deletion
C Stavropoulou, C Sambani, H Rigana, V N Georgakakos, G Voutsinas, K N
Manola, G E Pantelias and V Makropoulos
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21p0E6
MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral
immune responses in patients with multiple myeloma
A Curioni-Fontecedro, A J Knights, M Tinguely, N Nuber, C Schneider, C
W Thomson, L von Boehmer, W Bossart, S Pahlich, H Gehring, H Moch, C
Renner, A Knuth and A Zippelius
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21q0E7
----------------------
CORRIGENDA
----------------------
The role of vertebral augmentation in multiple myeloma: International
Myeloma Working Group Consensus Statement
M A Hussein, F D Vrionis, R Allison, J Berenson, S Berven, E Erdem, S
Giralt, S Jagannath, R A Kyle, S LeGrand, R Pflugmacher, N Raje, S V
Rajkumar, R L Randall, D Roodman, D Siegel, R Vescio, J Zonder and B G
M Durie
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21r0E8
Making progress in treating multiple myeloma with total therapies:
issue of complete remission and more
B Barlogie, F van Rhee, J D Shaughnessy, E Anaissie and J Crowley
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20B21s0EA
------------------------------------------------------------------
ESO e-grandround
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20BrPN0E7
The European School of Oncology in partnership with
Nature Clinical Practice Oncology is pleased to announce live
e-grandrounds. These online discussion-based presentations allow
participants to submit questions and take part in lively
discussions. We invite you to join the e-grandrounds, which are
broadcast every other Thursday from 17:15-18:00 GMT.
Please visit
http://ealerts.nature.com/cgi-bin24/DM/y/emtO0Xztnp0Hi20BrPk0Eb
for further information.
======================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and
Wales under company number 785998 and whose registered office is located
at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
(c) Copyright 2008 Nature Publishing Group
======================================================================
